Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Feb-24 6:49 PM View:  | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Payment of Exercise | 20,362 | $36.10 | $735,068.00 | (3%) 697.11K to 676.74K | |
| 20-Feb-24 6:49 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-24 | Option Exercise | 37,884 | -- | -- | 6% 659.22K to 697.11K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Grant | 32,781 | -- | -- | 5% 638.0K to 670.78K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Payment of Exercise | 24,655 | $35.91 | $885,361.00 | (4%) 683.88K to 659.22K | |
| 16-Feb-24 5:39 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-24 | Option Exercise | 13,092 | -- | -- | 2% 670.78K to 683.88K | |
| 13-Feb-24 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Payment of Exercise | 16,943 | $35.49 | $601,307.00 | (3%) 654.95K to 638.0K | |
| 13-Feb-24 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-24 | Option Exercise | 31,281 | -- | -- | 5% 623.67K to 654.95K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 31-Aug-23 | Planned Option Sale | 10,000 | $42.82 | $428,170.00 | (2%) 633.67K to 623.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 30-Aug-23 | Planned Option Sale | 10,000 | $42.85 | $428,540.00 | (2%) 633.67K to 623.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 31-Aug-23 5:35 PM View: | Halozyme Therapeutics, Inc. (HALO) | 29-Aug-23 | Planned Option Sale | 10,000 | $42.40 | $424,020.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 17-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 17-Aug-23 | Planned Option Sale | 10,000 | $43.18 | $431,820.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Aug-23 | Planned Option Sale | 10,000 | $43.53 | $435,320.00 | (2%) 633.67K to 623.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 17-Aug-23 5:29 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Aug-23 | Planned Option Sale | 10,000 | $43.77 | $437,680.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 27-Jul-23 | Planned Option Sale | 10,000 | $43.79 | $437,900.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 26-Jul-23 | Planned Option Sale | 10,000 | $42.69 | $426,890.00 | (2%) 633.67K to 623.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Jul-23 | Option Exercise | 10,000 | $13.87 | $138,700.00 | 2% 623.67K to 633.67K | |
| 27-Jul-23 4:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 25-Jul-23 | Planned Option Sale | 10,000 | $42.80 | $427,960.00 | (2%) 633.67K to 623.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Mar-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 623.67K to 633.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Mar-23 | Planned Option Sale | 10,000 | $42.73 | $427,270.00 | (2%) 633.67K to 623.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Mar-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 623.67K to 633.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Mar-23 | Planned Option Sale | 10,000 | $43.26 | $432,590.00 | (2%) 633.67K to 623.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 07-Mar-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 623.67K to 633.67K | |
| 09-Mar-23 5:04 PM View: | Halozyme Therapeutics, Inc. (HALO) | 07-Mar-23 | Planned Option Sale | 10,000 | $45.47 | $454,690.00 | (2%) 633.67K to 623.67K | |
| 01-Mar-23 6:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 01-Mar-23 | Gift | 10,000 | -- | -- | (2%) 633.67K to 623.67K | |
| 21-Feb-23 6:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-23 | Option Exercise | 21,010 | -- | -- | 3% 623.72K to 644.73K | |
| 21-Feb-23 6:59 PM View: | Halozyme Therapeutics, Inc. (HALO) | 16-Feb-23 | Option Sale | 11,061 | $49.26 | $544,865.00 | (2%) 644.73K to 633.67K | |
| 17-Feb-23 6:20 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-23 | Payment of Exercise | 6,892 | $49.20 | $339,086.00 | (1%) 630.61K to 623.72K | |
| 17-Feb-23 6:20 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Feb-23 | Option Exercise | 13,092 | -- | -- | 2% 617.52K to 630.61K | |
| 14-Feb-23 5:17 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-23 | Payment of Exercise | 17,266 | $48.92 | $844,653.00 | (3%) 634.78K to 617.52K | |
| 14-Feb-23 5:17 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-23 | Option Exercise | 32,794 | -- | -- | 5% 601.99K to 634.78K | |
| 14-Feb-23 5:17 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-23 | Payment of Exercise | 16,469 | $48.92 | $805,663.00 | (3%) 618.46K to 601.99K | |
| 14-Feb-23 5:17 PM View: | Halozyme Therapeutics, Inc. (HALO) | 10-Feb-23 | Option Exercise | 31,281 | -- | -- | 5% 587.18K to 618.46K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Feb-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 587.18K to 597.18K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 09-Feb-23 | Planned Option Sale | 10,000 | $50.40 | $504,000.00 | (2%) 597.18K to 587.18K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Feb-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 587.18K to 597.18K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 08-Feb-23 | Planned Option Sale | 10,000 | $51.36 | $513,570.00 | (2%) 597.18K to 587.18K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 07-Feb-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 587.18K to 597.18K | |
| 09-Feb-23 5:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 07-Feb-23 | Planned Option Sale | 10,000 | $51.26 | $512,580.00 | (2%) 597.18K to 587.18K | |
| 19-Jan-23 5:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 19-Jan-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 587.18K to 597.18K | |
| 19-Jan-23 5:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 19-Jan-23 | Planned Option Sale | 10,000 | $52.41 | $524,140.00 | (2%) 597.18K to 587.18K | |
| 19-Jan-23 5:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 18-Jan-23 | Option Exercise | 10,000 | $14.66 | $146,600.00 | 2% 587.18K to 597.18K | |
| 19-Jan-23 5:07 PM View: | Halozyme Therapeutics, Inc. (HALO) | 18-Jan-23 | Planned Option Sale | 10,000 | $51.05 | $510,470.00 | (2%) 597.18K to 587.18K |